Anda mungkin berminat pada artikel ini
AstraZeneca sets out $15 billion China investment during Starmer visit
US to initially impose 'small tariff' on pharma imports, Trump says
AstraZeneca umum pelan pelaburan US$50 bilion di AS di tengah ancaman tarif Trump
Tariff wars to hit popular US-made drugs in China, regulator data shows
Syarikat farmasi British janji pelaburan AS$2.5 bilion di Beijing
Menelusuri landskap penyakit jarang jumpa di Asia